Charčiūnaitė Karolina, Gauronskaitė Rasa, Šlekytė Goda, Danila Edvardas, Zablockis Rolandas
Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Clinic of Chest Diseases, Immunology and Allergology, Institute of Clinical Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Medicina (Kaunas). 2021 Apr 1;57(4):335. doi: 10.3390/medicina57040335.
: Obstructive sleep apnea (OSA) is a heterogeneous chronic sleep associated disorder. A common apnea-hypopnea index (AHI)-focused approach to OSA severity evaluation is not sufficient enough to capture the extent of OSA related risks, it limits our understanding of disease pathogenesis and may contribute to a modest response to conventional treatment. In order to resolve the heterogeneity issue, OSA patients can be divided into more homogenous therapeutically and prognostically significant groups-phenotypes. An improved understanding of OSA phenotype relationship to treatment effectiveness is required. Thus, in this study several clinical OSA phenotypes are identified and compared by their treatment effectiveness. : Retrospective data analysis of 233 adult patients with OSA treated with continuous positive airway pressure (CPAP) was performed. Statistical analysis of data relating to demographic and anthropometric characteristics, symptoms, arterial blood gas test results, polysomnografic and respiratory polygraphic tests and treatment, treatment results was performed. : 3 phenotypes have been identified: "Position dependent (supine) OSA" (Positional OSA), "Severe OSA in obese patients" (Severe OSA) and "OSA and periodic limb movements (PLM)" (OSA and PLM). The highest count of responders to treatment with CPAP was in the OSA and PLM phenotype, followed by the Positional OSA phenotype. Treatment with CPAP, despite the highest mean pressure administered was the least effective among Severe OSA phenotype. : Different OSA phenotypes vary significantly and lead to differences in response to treatment. Thus, treatment effectiveness depends on OSA phenotypes and treatment techniques other than CPAP may be needed. This emphasizes the importance of a more individualized approach when treating OSA.
阻塞性睡眠呼吸暂停(OSA)是一种异质性慢性睡眠相关疾病。以常见的呼吸暂停低通气指数(AHI)为重点的OSA严重程度评估方法不足以全面反映OSA相关风险的程度,它限制了我们对疾病发病机制的理解,并且可能导致对传统治疗的反应有限。为了解决异质性问题,OSA患者可被分为治疗和预后方面更具同质性的重要组——表型。需要更好地理解OSA表型与治疗效果之间的关系。因此,在本研究中,通过治疗效果识别并比较了几种临床OSA表型。
对233例接受持续气道正压通气(CPAP)治疗的成年OSA患者进行了回顾性数据分析。对与人口统计学和人体测量学特征、症状、动脉血气测试结果、多导睡眠图和呼吸多导图测试及治疗、治疗结果相关的数据进行了统计分析。
已识别出3种表型:“体位依赖性(仰卧位)OSA”(体位性OSA)、“肥胖患者的重度OSA”(重度OSA)和“OSA与周期性肢体运动(PLM)”(OSA与PLM)。CPAP治疗反应者数量最多的是OSA与PLM表型,其次是体位性OSA表型。在重度OSA表型中,尽管给予的平均压力最高,但CPAP治疗效果最差。
不同的OSA表型差异显著,导致治疗反应不同。因此,治疗效果取决于OSA表型,可能需要CPAP以外的治疗技术。这强调了治疗OSA时采用更个体化方法的重要性。